Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.

Saved in:
Bibliographic Details
Title: Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.
Authors: Tsang PS; Oncogenomics Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Cheuk AT, Chen QR, Song YK, Badgett TC, Wei JS, Khan J
Source: BMC cancer [BMC Cancer] 2012 Mar 21; Vol. 12, pp. 101. Date of Electronic Publication: 2012 Mar 21.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2407
DOI:10.1186/1471-2407-12-101